Maintaining proper nutrient status supports energy, neurological function, and overall well-being during treatment
The consistently higher rates of treatment adherence, persistence, and glycemic control compared to other GLP1 RAs position dulaglutide as a preferred choice for initiating injectable AHA therapy in this patient population
Our care model is designed to address boththoughtfully, safely, and with close medical support
Improved Adherence The ease of oral administration can lead to better treatment adherence, improving overall patient outcomes
Differential gene expression profiles of red and green forms of Perilla frutescens leading to comprehensive identification of anthocyanin biosynthetic genes
These drugs work by mimicking the action of endogenous GLP-1 but at supraphysiological doses, resulting in stronger and longer-lasting effects on appetite suppression